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Information on gene clusters for natural product
biosynthesis is accumulating rapidly because of
the current boom of available genome sequencing
data. However, linking a natural product to a specific
gene cluster remains challenging. Here, we present a
widely applicable strategy for the identification of
gene clusters for specific natural products, which
we name natural product proteomining. The method
is based on using fluctuating growth conditions that
ensure differential biosynthesis of the bioactivity of
interest. Subsequent combination of metabolomics
and quantitative proteomics establishes correlations
between abundance of natural products and
concomitant changes in the protein pool, which
allows identification of the relevant biosynthetic
gene cluster. We used this approach to elucidate
gene clusters for different natural products in Bacil-
lus and Streptomyces, including a novel juglomy-
cin-type antibiotic. Natural product proteomining
does not require prior knowledge of the gene cluster
or secondary metabolite and therefore represents a
general strategy for identification of all types of
gene clusters.
INTRODUCTION
Because of the rapid spread of drug-resistant infectious dis-
eases, a point of no return has been reached where novel antibi-
otics are of absolute necessity (Payne et al., 2007). However, it
has become increasingly difficult to find novel antibiotics with
efficacy against multidrug-resistant pathogens such as MDR-
TB (multidrug-resistant Mycobacterium tuberculosis), MRSA
(methicillin-resistant Staphylococcus aureus), and the rapidly
emerging multidrug-resistant Gram-negative pathogens (Arias
and Murray, 2009; Rice, 2008). The actinomycetes are filamen-
tous bacteria with a complex multicellular life cycle (Claessen
et al., 2014) that produce some two-thirds of all known natural
antibiotics (Hopwood, 2007). Full genome sequencing estab-Chemistry & Biology 21,lished that even the widely studied species are relatively
untapped sources of natural products, such as antibiotics,
anticancer agents, and fungicides (Hopwood et al., 1995). For
example, over 20 gene clusters for natural products biosynthesis
are present on the genome of Streptomyces coelicolor A3(2)
alone (Bentley et al., 2002). This suggests the presence of silent
biosynthetic gene clusters in all actinomycetes, sequenced and
unsequenced, and new approaches are required to identify
and characterize these (Challis and Hopwood, 2003; Van Lanen
and Shen, 2006).
Genome mining based on next generation sequencing (NGS)
(Claesen and Bibb, 2010; Cruz-Morales et al., 2013; Ikeda
et al., 2014; Lautru et al., 2005; Udwary et al., 2011) and meta-
genomics (Owen et al., 2013) are valuable strategies to aid in
the discovery and identification of natural products. With the
rapidly increasing number of sequenced genomes, the amount
of data on biosynthetic gene clusters is overwhelming. However,
although successful examples exist where natural products
were identified guided by the genome sequence alone (Knappe
et al., 2008; Lautru et al., 2005), this is still a challenging process.
For example, many biosynthetic gene clusters of the same class
can be present on a single genome, they might be spread over
multiple contigs, and each of them generally contains genes
with unknown function, causing ambiguity as to the predicted
structure of the products. Moreover, the products produced by
‘‘cryptic’’ gene clusters will likely remain undetected. Also,
many strains are not easily manipulated, whereas large scale
heterologous expression of metagenomic libraries is challenging
(Wilson and Piel, 2013). Consequently, new methods that allow
conclusive linkage between a gene cluster and a natural product
of interest are needed to facilitate efficient genome mining-
based drug discovery.
Expression-based analysis is a useful tool to detect active
biosynthetic gene clusters (Schley et al., 2006; Udwary et al.,
2011). By exploiting the essential phosphopantetheine modifica-
tion of polyketide synthases (PKS) and nonribosomal peptide
synthases (NRPS), two proteomics-based approaches have
been designed to specifically detect these proteins, either after
affinity purification (Meier et al., 2009) or by detection of reporter
ions by mass spectrometry (Bumpus et al., 2009). In case no
genome sequence information is available, peptides of interest
are sequenced de novo to design degenerate primers for PCR
amplification of parts of the gene cluster. An alternative is PCR707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 707
Table 1. Expression Level Changes of Proteins and Secondary
Metabolites in S. coelicolor
2Log Ratio (Mutant/WT)a
ProductbDasR Rok7B7
Protein Levels
desferrioxamine
2.8 1.0 SCO2782 (DesA)
3.0 1.9 SCO2785 (DesD)
undecylprodigiosin
1.4 SCO5878 (RedX)
1.7 SCO5879 (RedW)
1.9 SCO5888 (FabH3)
1.8 1.9 SCO5890
2.1 SCO5891 (RedM)
2.1 SCO5892
2.2 1.9 SCO5895
2.0 SCO5896
Metabolite Levels
1.1 2.0 desferrioxamine mycelium
3.2 4.2 desferrioxamine excreted
3.3 2.6 prodiginin mycelium
See also Figure S1.
aChanges in protein levels expressed as signal intensity in dasR or rok7B7
deletion mutants versus signal intensity in the parental strain S. coelicolor
M145. For quantitative proteomics, data are the averages of two experi-
ments, with one experiment using opposite labeling compared with the
other experiment (label swap). Italic numbers indicate that the ratio could
only be determined in one of the two experiments and are included only if
the same protein could be quantified (detected in both experiments with
same sign) for the other deletion mutant. For metabolites, ratios were
determined by LC-MS analysis and peak integration.
bGene/protein annotations based on StrepDB (http://strepdb.
streptomyces.org.uk).
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Natural Product Proteominingamplification of cDNA, using degenerate primers for sequences
common in biosynthetic gene clusters (Qu et al., 2011). Yet
another strategy utilizes sequence tags, obtained from peptides
or glycosylated natural products using tandem mass spectrom-
etry (MS) analysis to link the natural products to gene clusters in
previously sequenced organisms (Kersten et al., 2011; Kersten
et al., 2013). These methods target specific types of clusters or
known sequences; for example lantibiotics, which are ribo-
somally produced peptides subsequently modified via, among
other means, lanthionine-type thioether crosslinking (Willey
and van der Donk, 2007), cannot be detected in this way. There-
fore, a single, straightforward method to identify the biosynthetic
cluster of all types of secondary metabolites is of great interest.
The production of secondary metabolites varies greatly
depending on external factors such as growth and nutritional
conditions (Sa´nchez et al., 2010; van Wezel and McDowall,
2011). In several streptomycetes the production of poorly ex-
pressed antibiotics may be induced by the addition of N-acetyl-
glucosamine, which relieves repression of biosynthetic gene
clusters by the global regulator DasR (Rigali et al., 2008). Utilizing
the ability to achieve strong fluctuation in secondary metabolism
under different growth conditions, we developed the natural708 Chemistry & Biology 21, 707–718, June 19, 2014 ª2014 Elsevierproduct proteomining approach, which allows correlating
quantified levels of a secondary metabolite or bioactivity of inter-
est to the concomitant changes in global protein expression
profiles as analyzed by quantitative proteomics. In this study,
we first demonstrate the positive correlation between the levels
of the biosynthetic proteins and of the secondary metabolites
they produce, irrespective of the nature of the metabolite. This
was then applied to identify the gene clusters responsible for
the biosynthesis of antibiotics in previously uncharacterized
soil isolates. Because this method requires preidentification
neither of the gene clusters nor of the natural product of interest,
it allows identification of biosynthetic gene clusters of all types of
natural products, requiring only a partial genome sequence from
a single run of NGS sequencing.
RESULTS
Correlation between Protein Expression and Secondary
Metabolite Production
To investigate the correlation between the expression level of
biosynthetic proteins and the amount of metabolite, we selected
the dasR- and rok7B7-null mutants of the model actinomycete
S. coelicolor A3(2). Both genes specify global regulators of
metabolism in response to nutrient availability (Rigali et al.,
2008; Swia˛tek et al., 2013), and their null mutants show strong
differential production of, among others, the readily detectable
polyketide antibiotic undecylprodigiosin and the siderophore
desferrioxamine (Craig et al., 2012). Because both products
and their gene clusters have been well characterized (Barona-
Go´mez et al., 2004; Feitelson et al., 1985), they form ideal candi-
dates to test the correlation between protein expression and
production.
S. coelicolor M145 and its congenic dasR- and rok7B7-null
mutants were grown in liquid minimal medium containing either
14N or 15N as the sole nitrogen source, until the late logarithmic
phase when production of the red-pigmented antibiotic undecyl-
prodigiosin became apparent. Stable isotope-labeled protein
extracts (14N/15N) were mixed and separated by SDS-PAGE,
followed by liquid chromatography (LC)-MS analysis of individ-
ual gel slices (Figure S1A available online). The metabolic label-
ing allowed for relative quantification of protein level changes
between the parent and mutant strains. To filter out anomalies
caused by minor differences in the isotope-labeled growth
medium, only expression ratios with opposing signs in a label-
swap experiment were retained. In total, expression of 346
proteins was significantly changed in either mutant, as
compared with the parental strain M145 (Figure S1B). As ex-
pected, substantial expression changes were observed for
proteins involved in secondary metabolite production, including
production of desferrioxamines (Table 1; upregulated in both)
and prodiginines (downregulated in dasR-null mutant and upre-
gulated in rok7B7-null mutant).
In parallel, metabolite levels were determined by LC-MS for
both mycelial (biomass) and spent medium (supernatant)
samples from the same cultures. Both desferrioxamine B (m/z
614) and undecylprodigiosin/streptorubin B (m/z 392 and 394)
were readily detected (Figure S1C) (Mo et al., 2008). LC-MS
peak integration for mycelia demonstrated that desferrioxamine
B levels were approximately 4-fold higher in the rok7B7 deletionLtd All rights reserved
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Figure 1. Proteomics Analysis of Mersacidin Production
B. amyloliquefaciens HIL-Y85/54728 was grown in the indicated media:
production medium (PM), LB, or TSB.
(A) After 5 days, spent media samples were subjected to MALDI-ToF MS
analysis. Mersacidin production was observed when grown in PM only. The
other peaks in the mass range shown corresponded to sodium and potassium
adducts of these three isoforms.
(B) Protein extracts after 1 day of growth were subjected to proteomics
analysis. Mersacidin was already detected after 1 day, albeit at low intensity
(not shown). All six detected proteins involved in mersacidin production
demonstrated elevated levels in production medium.
See also Data Set S1.
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Natural Product Proteominingmutant and 2-fold higher in the dasR deletion mutant as
compared with the parental strain M145 (Table 1). Undecyl-
prodigiosin/streptorubin B were significantly reduced in the
dasR-null mutant (<10% of wild-type levels), whereas levels
were approximately 6-fold higher in the rok7B7 mutant.
These results confirm our hypothesis that protein expression
levels and secondary metabolite production are strongly
correlated.
We then wondered whether this observation could be
extended to different types of secondary metabolites and to
other microorganisms. Therefore, we analyzed Bacillus amyloli-
quefaciens HIL-Y85/54728, which produces the type B lantibi-
otic mersacidin, the biosynthesis of which is specified by a
gene cluster consisting of ten coding sequences (CDSs) (Altena
et al., 2000). Matrix-assisted laser desorption ionization-time ofChemistry & Biology 21,flight (MALDI-ToF) MS analysis of spent medium revealed that
it was produced when B. amyloliquefaciens was grown in a
synthetic production medium but not in the rich media tryptic
soy broth (TSB) or Lucia broth (LB) (Figure 1A). Protein extracts
were prepared from the same cultures and expression profiles
correlated to the levels of mersacidin. Because the variation of
growth conditions, including use of different nitrogen sources,
ruled out 15N metabolic labeling, dimethyl labeling of peptides
(Boersema et al., 2009) was used for quantitative proteomics.
Labeled peptides were first fractionated by strong cation
exchange (SCX)-high-performance liquid chromatography
(HPLC), followed by LC-MS analysis of each fraction. This
resulted in the quantification of expression levels of six of the
ten mersacidin producing proteins, including the prepeptide
MrsA (Figure 1B). Expression of all proteins was upregulated in
the production medium, exemplified by the immunity proteins
MrsF and MrsG and the modification protein MrsM (at least
20-fold upregulated). The cluster-specific regulator MrsR2 was
less strongly upregulated (less than 2-fold) than the biosynthetic
proteins, which is in line with previous observations (van Wezel
and McDowall, 2011). The complete proteomics data are pre-
sented in Data Set S1.
The observation that protein expression levels are directly
proportional to the amount of secondary metabolite produced,
regardless of the type of cluster or species, forms the basis for
our natural product proteomining approach (Figure 2A): fluctua-
tions in the proteome pool can be correlated to changes in a
bioactivity of interest and/or the metabolome (as measured by
MS and/or nuclear magnetic resonance [NMR]). Comparison of
multiple culturing conditions and subsequent filtering of the
proteomics data should allow identification of the relevant
biosynthetic gene cluster in principal regardless of the exact
nature of the secondary metabolite. Subsequent analysis of
the cluster will aid compound identification.
Proteomining of a Soil Isolate Positively Identifies
Actinomycin as a Source of Antibiotic Activity
Can natural product proteomining be applied with equal effi-
ciency to an unknown natural isolate with a partial genome
sequence obtained from a single NGS run? For this, a sufficiently
accurate partial proteome prediction is required to identify the
majority of the proteins, as well as significant variation in the
expression of the compound of interest. To achieve the latter,
many growth conditions were tested on a strain collection of
some 800 actinomycetes to identify conditions that qualify best
to achieve strong variation in the levels of natural products
(H.Z., et al., submitted). Generally, comparison of liquid-grown
minimal medium cultures supplied with growth conditions A
(NaOH to pH 9), B (25 mM N-acetylglucosamine), C (0.8%
[w/v] Bacto peptone [Difco]); D (0.5% [w/v] yeast extract), E
(1%–2% [w/v] NaCl), or () (no additive) gave good variation in
bioactivity.
A previously uncharacterized natural isolate from forest soil,
Streptomyces sp. Che1, was analyzed, which produces a
yellow/orange pigment with strong antimicrobial activity. The
strain was grown for 5 days using the five additives mentioned
above, and supernatants were tested for antibiotic activity using
the Gram-positive bacteriumMicrococcus luteus as an indicator
strain (Figure 2B). Supernatants obtained after growth under707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 709
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A Figure 2. Natural Product Proteomining of
Streptomyces sp. Che1 and MBT70
(A) General overview of the natural product pro-
teomining method.
(B) Streptomyces sp. Che1 and MBT70 were
grown in liquid NMMP media for 3–5 days
using five different additives: A (NaOH to pH 9), B
(25 mM N-acetylglucosamine), C (0.8% [w/v]
Bacto peptone [Difco]), D (0.5% [w/v] yeast
extract), and E (1%–2% [w/v] NaCl), or ()
(no additive). Spent medium samples were tested
for antibiotics production using M. luteus as indi-
cator strain.
(C) In parallel, protein expression levels in mycelia
were compared using quantitative proteomics.
Stable isotope labeling was performed through
dimethylation of tryptic peptides. Because
this method allows the comparison of three
samples simultaneously, two experiments were
performed, using one condition with the
highest activity (condition 1) as a shared condition. The other four conditions (conditions 2–5) could thus be compared with the shared condition and
one other condition (conditions 2 and 3 or conditions 4 and 5).
See also Figure S2.
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Natural Product Proteominingcondition A showed highest antimicrobial activity, and those
obtained under conditions C and D effected medium growth
inhibition, whereas the strain did not show detectable antimicro-
bial activity when grown under conditions B or E. MALDI-ToFMS
analysis (Figure S2) identified multiple major peaks in the range
of 1,255–1,330 Da for samples A, C, and D. The mass
differences between the peaks corresponded to methylation
(CH2, +14 Da) and/or the presence of Na
+ (+22 Da) or K+ (+38
Da) adducts, indicating that they were probably related. Signal
intensities for all peaks demonstrated high correlation to antibi-
otic activity: high signal for condition A, low signal for conditions
C and D, and no detectable signal for the other conditions (after
normalization based on other signals observed in the MS
spectra). Upon fractionation, the peaks were retained in the
active fraction, and subsequent 1H NMR spectroscopy revealed
the presence of actinomycin as active compound (data not
shown). Indeed, the observed masses corresponded exactly to
those measured for pure actinomycin C2, C3, and D (C1; Fig-
ure S2) (Keller et al., 2010).
The partial genome sequence of Streptomyces sp. Che1 was
obtained using a single run of paired end Illumina sequencing,
and the output was assembled in 919 contigs. Identification of
biosynthesis clusters using AntiSMASH (Blin et al., 2013)
revealed the presence of 57 (partial) putative biosynthetic clus-
ters. CDSs were predicted using the GeneMark algorithm, and
8,812 putative (and possibly partial) protein sequences were
derived as a database for proteomics analysis. Because only
three different labels are available in dimethyl labeling, the sam-
ples were compared in two independent quantitative proteomics
experiments with one sample in common (samples A, B, and C
and samples A, D, and E, respectively), with each experiment
containing at least one sample of high activity and one sample
of low activity (Figure 2C). Protein quantifications of the two
experiments were combined, resulting in the identification of
2,645 proteins for Che1, with 1,863 proteins quantified in all
comparisons with at least three independent events (Data Set
S2). Importantly, expression of 52 predicted biosynthetic clus-
ters (91%) could be detected. Based on the expression ratios710 Chemistry & Biology 21, 707–718, June 19, 2014 ª2014 Elsevierand for each comparison independently, the proteins were
divided into three quantiles, each containing an equal number
of proteins: Q1 (downregulated), Q2 (unchanged), or Q3
(upregulated).
By using the NUCmer algorithm (Kurtz et al., 2004), seven
contigs were positively mapped to the actinomycin gene cluster
(Keller et al., 2010) (GenBank accession number HM038106,
48 kb) with 91% sequence coverage. In total, the products of
28 predicted open reading frames (ORFs) were detected and
quantified in our experiment (Table 2), with the sequence of the
large NRPS proteins AcmB and AcmC split over multiple CDSs
and contigs, most likely because of the repetitive nature of the
DNA sequence for these types of CDSs, leading to some mis-
assembly. Two CDSs in contig 981 (CDSs 1 and 12) demon-
strated expression level ratios in the correct quantile for all six
comparisons out of only 34 CDSs for the complete proteome
and, importantly, were the only two such hits clustered together
on a single contig. Thus, the proteomics result seems to confirm
that actinomycin is produced and responsible for the observed
antibiotic activity.
However, because most CDSs in the actinomycin cluster did
not match the correct pattern for all six comparisons, we anti-
cipated that filtering might be more realistic by using only the
four comparisons that included the proteome for the culture
grown under condition A, because this culture demonstrated
high activity (Figure 2B) and high actinomycin levels (Figure S2)
as compared with the other conditions. Indeed, all potential
CDSs in the central region of the actinomycin cluster (acmT–
acmI, 18 CDSs) matched this filter condition (Table 2; Figure S3).
Considering that the central region of the cluster contains the
CDSs for the biosynthetic proteins, whereas the flanking regions
contain genes coding for resistance and regulation (Keller et al.,
2010), this again confirmed that expression levels of the biosyn-
thetic proteins best match metabolite levels.
Relaxing the filter conditions to only four comparisons inevi-
tably increased the number of hits in the total proteome consid-
erably to 298 CDSs. Still, only seven contigs contained at least
five matching CDSs clustered together (<10 nonmatching orLtd All rights reserved
Table 2. Expression Level Changes of CDSs Coding for Actinomycin Biosynthesis
contig CDS Gened
Normalized Ratios (2log)a Quantilesb Countc
B/A C/A C/B D/A E/A E/D B/A C/A C/B D/A E/A E/D B/A C/A C/B D/A E/A E/D
981 23 acmrc 2.8 0.0 2.4 3.5 3.3 0.3 Q1 Q2 Q3 Q1 Q1 Q3 40 40 40 26 26 26
981 22 acmrb 3.1 0.3 2.8 2.9 2.0 1.9 Q1 Q2 Q3 Q1 Q1 Q3 7 7 7 9 9 9
981 21 acmra 3.6 0.3 3.2 4.2 3.6 0.9 Q1 Q2 Q3 Q1 Q1 Q3 31 31 31 22 22 22
981 20 acmq 2.8 0.9 3.3 3.2 1.7 1.4 Q1 Q3 Q3 Q1 Q1 Q3 60 60 60 62 60 60
981 19 acmq 2.0 1.0 2.9 3.6 2.6 0.9 Q1 Q3 Q3 Q1 Q1 Q3 16 16 16 9 9 9
981 18 acmp 1.7 0.9 2.4 1.3 1.6 0.1 Q1 Q3 Q3 Q2 Q1 Q2 7 7 7 5 5 5
981 12 acmt 2.8 2.2 0.4 2.1 3.8 0.8 Q1 Q1 Q3 Q1 Q1 Q1 11 11 11 18 16 16
981 11 acms 2.6 2.3 0.4 3.5 3.0 0.3 Q1 Q1 Q3 Q1 Q1 Q3 52 52 52 61 57 57
981 8 acma 2.5 1.2 1.2 3.7 3.0 0.9 Q1 Q1 Q3 Q1 Q1 Q3 39 38 38 38 33 33
981 4 acmb 3.6 3.1 0.5 4.0 4.7 0.4 Q1 Q1 Q3 Q1 Q1 Q2 20 20 20 25 23 23
981 1 acmc 2.1 1.2 0.6 4.0 4.6 1.0 Q1 Q1 Q3 Q1 Q1 Q1 15 15 15 9 9 9
237 4 acmb/c 3.1 2.6 0.6 3.9 3.1 1.0 Q1 Q1 Q3 Q1 Q1 Q3 72 72 72 84 81 81
237 6 acmb/c 3.4 2.4 0.9 3.8 3.2 0.2 Q1 Q1 Q3 Q1 Q1 Q3 44 44 44 43 41 41
237 7 acmc 3.0 2.4 0.4 4.3 2.5 1.9 Q1 Q1 Q3 Q1 Q1 Q3 12 12 12 15 15 15
1020 1 acmb 3.7 2.5 1.0 3.4 4.0 1.1 Q1 Q1 Q3 Q1 Q1 Q3 23 23 23 14 14 14
1020 2 acmb/c 3.3 2.5 0.6 3.7 2.3 0.5 Q1 Q1 Q3 Q1 Q1 Q3 11 11 11 13 13 13
414 1 acmb/c 1.4 2.0 0.7 3.6 4.0 0.0 Q1 Q1 Q1 Q1 Q1 Q2 3 3 3 3 3 3
925 1 acmb/c 3.8 2.7 1.0 1.7 1.6 0.4 Q1 Q1 Q3 Q1 Q1 Q3 7 7 7 4 4 4
816 1 acmc 3.5 2.4 0.8 3.7 3.9 0.4 Q1 Q1 Q3 Q1 Q1 Q3 46 46 46 46 38 38
816 2 acmc 2.9 1.8 1.0 3.2 3.1 0.7 Q1 Q1 Q3 Q1 Q1 Q3 39 39 39 44 42 42
816 3 acme 2.2 2.7 0.1 3.2 2.1 0.6 Q1 Q1 Q2 Q1 Q1 Q3 10 10 10 16 15 15
816 4 acmf 2.8 3.5 0.5 4.9 3.0 1.8 Q1 Q1 Q1 Q1 Q1 Q3 3 3 3 5 5 5
816 7 acmh 2.0 2.6 0.2 2.3 2.3 0.3 Q1 Q1 Q2 Q1 Q1 Q3 15 15 15 21 20 20
816 8 acmi 3.2 2.8 0.4 4.3 3.8 0.5 Q1 Q1 Q3 Q1 Q1 Q3 103 100 100 106 99 99
816 10 acmu 2.7 0.9 3.4 Q1 Q3 Q3 4 4 4 2 2 2
816 11 acmv 2.7 0.1 2.8 3.6 3.5 0.3 Q1 Q3 Q3 Q1 Q1 Q3 40 40 40 32 32 32
793 16 acmw 3.8 0.3 3.2 2.6 3.4 0.7 Q1 Q2 Q3 Q1 Q1 Q1 14 14 14 10 10 10
793 14 acmy 1.7 0.4 1.9 Q1 Q3 Q3 5 5 5 2 2 2
See also Figure S3 and Data Set S2.
aChanges in protein expression levels observed for the indicated CDSs when compared between growth conditions A–E.
bExpression ratioswere divided in three equally sized quantiles for each experiment. Where the expression level change corresponded to the expected
quantile, this is indicated in bold. Where all four comparisons used for filtering (containing condition A, indicated in bold) matched to the expected
quantile, the CDS number is also indicated in bold.
cThe number of quantifications events used to calculate the expression ratios. Quantifications based on less than three events (italicized) were
discarded.
dGene name according to GenBank.
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Natural Product Proteominingundetected CDSs in between; Table 3), of which two contigs
(816 and 981) were part of the actinomycin cluster. Closer in-
spection of the other contigs by annotation based on BLAST
similarity searches suggested that two contained genes for the
NADH-dehydrogenase complex, whereas the other three con-
tained features related to natural product biosynthesis. When
the threshold value was lowered from five to three matching
CDSs per cluster, contig 237 from the actinomycin cluster (Table
2) was the only additional identified contig that clearly coded for
biosynthetic activity. In conclusion, relaxing filter conditions
added additional hits for the actinomycin cluster, together with
some false positives. Because actinomycin was the only match
when all six comparisons were considered and the expression
of the genes in the cluster correlated well with the bioactivity
for the four comparisons with the largest variation in activity,Chemistry & Biology 21,this validated our approach for application to link bioactivity to
a gene cluster in soil isolates.
Identification of a Juglomycin
For further support of our method, we analyzed the previously
undescribed soil isolate Streptomyces sp.MBT70. Supernatants
from cultures grown for 4 days under conditions C and E con-
tained strong antimicrobial activity, whereas those from cultures
grown under condition D had slightly lower activity (Figure 2A).
Hardly any or no activity was seen under conditions ([minus])
and B, respectively.
Sequencing of MBT70 yielded 396 contigs coding for 8,449
potential protein sequences and 56 (partial) putative biosynthetic
clusters. Protein expression profiles of cultures grown under
conditions ([minus]), C, and E (experiment 1) and conditions B,707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 711
Table 3. Candidate Clusters Demonstrating Expected Expression Level Changes
Contiga Quantifiedb Matching Total CDSs Anti-SMASHc Blast Analysisd GenBank Accession Number
Sp. Che1
42 6 5 6 + Streptomyces sp. W007 NRPS AGSW0100016
412 6 6 6 NADH dehydrogenase
419 7 6 8 NADH dehydrogenase
814 18 17 21 + nonactin AF263011, AF074603
816 6 6 8 + actinomycin HM038106
981 5 5 12 + actinomycin HM038106
1256 10 8 18 + skyllamycin JF430460
Sp. MBT70
Up in C and E
561 4 3 5 + S. antibioticus polyketide Y19177
Up in D
43 11 9 15 – ATP synthase
45 7 7 14 – sugar metabolism
443 13 13 22 + S. ansochromogenes pks2 KF170322
See also Tables S1 and S2 and Data Sets S2 and S3.
aChanges in protein expression levels were compared between growth conditions (A–E and no additive (); see main text and Figure 2). Expression
ratios were divided in three equally sized quantiles for each comparison and filtered based on the four (three for MBT70, up in D) comparisons with the
largest change in antibacterial activity (see main text). Contigs with at least five matching CDSs in a cluster (maximum gap < 10 CDSs) were selected.
For Streptomyces sp. MBT70, only one cluster upregulated in C and E with a maximum of three matching CDSs could be identified.
bThe region between the first matching CDS and last matching CDS was defined as a cluster as to compare the number of quantified CDSs and the
number of matching CDSs to the total number of CDSs in the cluster.
cClusters were analyzed with antiSMASH v2.0 (Blin et al., 2013) for the presence of secondary metabolite biosynthesis clusters. A hit is indicated with a
plus sign.
dSequences were compared using BLAST analysis to known streptomycetes sequences in the NCBI nr/nt and WGS (genomic shotgun sequences)
databases. Hits with more than 95% identity were used for annotation.
Chemistry & Biology
Natural Product ProteominingC, and D (experiment 2) were compared by quantitative prote-
omics (Figure 2B), yielding 2,132 protein identifications, with
1,087 proteins quantified in all comparisons (Data Set S3). Again,
expression of a high number of predicted clusters was detected
(48 clusters, 86%). Similar filtering as described for Strepto-
myces sp. Che1 was applied to Streptomyces sp. MBT70,
comparing conditions C and E with high antimicrobial activity
to the other conditions with reduced or no activity. With three
clustered hits, only CDSs 118–122 on contig 561 matched the
criteria (Figure 3A; Table 3). However, the ratio found for the
comparison between conditions C and D was striking (Table
S1; Figure S3), suggesting that little or no compound was
produced under condition D. Therefore, the data were reana-
lyzed using the three comparisons, including condition D (upre-
gulation) and condition B (no change or downregulated). This
identified three contigs with more than five matching hits
(Table 3), with the top hit (contig 443, 13 matches, specifically
upregulated in condition D; Table S2) encoding a PKS type I
(GenBank accession number KF170322) with a yet unknown
product (Zhong et al., 2013). Additional BLASTN analysis re-
vealed that contig 549 also contained part of this cluster, giving
a total of 17 matching CDSs (Table S2; Figure S3).
The candidate cluster in contig 561 is highly similar (>98%
nucleotide identity) to a PKS gene cluster in Streptomyces
antibioticus (GenBank accession number Y19177) (Colombo
et al., 2001) for the first, shared steps in the biosynthesis of
pyranonaphthoquinones, a class of compounds that includes
actinorhodin, granaticin, and medermycin (Hopwood, 1997;712 Chemistry & Biology 21, 707–718, June 19, 2014 ª2014 ElsevierMetsa¨-Ketela¨ et al., 2013). However, a gene encoding a homolog
of the actinorhodin biosynthetic protein ActIV of S. coelicolor,
catalyzing the final common step to a bicyclic intermediate, is
missing from this cluster; this suggested that genes specifying
subsequent steps might be located elsewhere on the MBT70
genome. TBLASTN analysis using the protein sequences from
the actinorhodin cluster as input identified a gene for a homolog
of ActIV (52% amino acid identity) 115 CDSs upstream of the
candidate gene cluster in contig 561 (CDS3; Figures 3A and
3B). Importantly, homologs were also detected for other genes
from the actinorhodin cluster and were located next to the can-
didate cluster and near the cyclase gene. Two additional proteo-
mining hits were found in the genomic region near the cyclase
gene (CDS11 and CDS12; Table S1), one of which was homo-
logous to actVI-ORF1. Because CDS128 (final CDS), CDS1,
and CDS2 specify the biotin binding, biotin carboxylase, and
the carboxyl transferase domains of acetyl-CoA carboxylase,
respectively, it seems likely that the last part and first part of
this contig should actually be continuous and that the two iden-
tified regions on this contig therefore form one biosynthetic gene
cluster (Figure 3A).
To link pyranonaphthoquinone biosynthesis under different
growth conditions to the observed bioactivity, NMR-based
metabolomics (Kim et al., 2010) was applied to EtOAc extracts
of spent media. 1H NMR spectra of five replicates of each con-
dition were analyzed by partial least square modeling-discrimi-
nant analysis (PLS-DA; Figures 4A and 4B). Conditions C and E
could be distinguished from the other conditions (Figure 4A),Ltd All rights reserved
AB
(actVA-ORF1, actll-ORF2)
MarR-like regulatory protein
Figure 3. Gene Cluster and Biosynthesis of a Juglomycin
(A) The biosynthetic gene cluster coding for the synthesis of a juglomycin-like compound 1. Annotations are based on BLAST homology searches. Based on the
annotation of the three acetyl-CoA carboxylase genes (depicted in red), the end and beginning of contig 561 of sp. MBT70were joined to yield one gene cluster. In
case CDS products demonstrated expected expression patterns changes in proteomining, the CDSs are depicted in bold.
(B) Proposed biosynthetic route to 1. The first, shared steps with pyranonaphthoquinone synthesis are indicated by a dashed box.
See also Figure S3, Table S1, and Table S3.
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duced in condition D. Main contributors to this difference were
several phenolic resonances (Figure 4B). In particular, the reso-
nance in d7.5–d7.6 was identified as an H-5 of naphthoquinone
type compounds, which was confirmed by the correlation be-
tween H-5 and C-4 in a heteronuclear multiple bonds correlationChemistry & Biology 21,(HMBC) spectrum (Figure 4C). Because naphthoquinones
demonstrate typical absorption of >400 nm, the extract of con-
dition E was subjected to HPLC fractionation on a C18 column,
and seven fractions that absorb at this wavelength were
collected, of which two demonstrated antibiotic activity against
M. luteus. 1H correlation spectroscopy, and HMBC-NMR707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 713
Figure 4. Metabolomics Analysis of Strep-
tomyces sp. MBT70
(A and B) Five biological replicates of Strepto-
myces sp. MBT70 were grown under the condi-
tions as described for Figure 2. 1H NMR spectra of
EtOAc extracts of spent mediumwere subjected to
PLS-DA to obtain score (A) and loading (B) plots.
The ellipse represents the Hotelling T2 with 95%
confidence. The arrow indicates the signal ob-
tained for H-5 of naphthoquinone.
(C) HMBC NMR spectrum of condition C in the
range of d5.2–d8.4 (horizontal axis for 1H) and d90–
d200 (vertical axis for 13C). Again, the arrow
indicates the signal obtained for H-5 of naph-
thoquinone.
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type compound in one fraction. Based on these data and high
resolution MS analysis ([M+H]+ 276.0869 m/z, C14H13NO5), we
propose that the gene cluster identified by proteomining spec-
ifies a juglomycin C-type compound (Lessmann et al., 1989)
with an amide functionality: b-(S),5-dihydroxy-1,4-naphthoqui-
none-2-butanamide (juglomycin C amide; Figure 3B, 1).
Juglomycin-type compound 2 was previously identified as an
actinorhodin shunt product in an S. coelicolor actVI-ORFA
mutant (Ozawa et al., 2003), probably because of inefficient
pyran ring formation (Figure 3B). Instead, the intermediate hemi-
ketal 3 isomerizes to 4, followed by C–C bond cleavage in a
retro-Claisen type reaction and oxidation to yield naphthoqui-
none 2. In our cluster, products of CDS123 (actVI-ORFA) and
CDS7 (actVI-ORF2, actVI-ORF4) might catalyze the isomeriza-
tion and subsequent C–C bond cleavage, instead of pyran ring
formation. For the oxidation step, CDS11 and CDS13 (actVB)
most probably specify a two-component flavin-dependent
monooxygenase system (Taguchi et al., 2013). Although
CDS11 is not an actVA-ORF5 homolog, its bicyclic substrate is
sufficiently different from the tricyclic intermediate in actinorho-
din biosynthesis to explain why an alternative luciferase-like
monooxygenase is used here. Finally, to yield 1, the products
of CDS18 and/or CDS19 likely catalyze amide formation, fol-
lowed by removal of acetate by the peptidase/esterase specified
by CDS8. Amidation would prevent lactonization to juglomycin
A/B as was observed for juglomycin C (Figure 3B) (Lessmann
et al., 1989). In conclusion, natural product proteomining of
Streptomyces sp. MBT70 yielded a juglomycin-type antibiotic
that was directly linked to its biosynthetic gene cluster. Subse-
quent analysis of the compound and the gene cluster confirmed
the proteomining result.714 Chemistry & Biology 21, 707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reservedDISCUSSION
The genome sequencing era has recently
led to the identification of unexpected
large numbers of biosynthetic gene
clusters in actinomycetes, often referred
to as cryptic or silent clusters because
of their poor expression under routine
laboratory conditions. Because soil iso-
lates can be notoriously difficult to manip-
ulate using common molecular biologicaltechniques, the application of eliciting conditions to induce
expression provides a promising alternative (Craney et al.,
2012; Zhu et al., 2014) because we could detect expression of
more than 85% of all predicted clusters in soil isolates. This, in
turn, calls for new technologies that allow the straightforward
linkage between a potentially novel natural product and its
biosynthetic gene cluster. Such a connection may help to ascer-
tain novelty of the compound, to guide fractionation and identifi-
cation attempts, and to allow molecular biological approaches,
possibly in combination with heterologous expression in a
suitable host (Komatsu et al., 2013). Our natural product proteo-
mining technology provides a concept for the connection of
theoretically any bioactivity—such as a secondary metabolite
with antimicrobial, antifungal, or anticancer activity—to a gene
cluster, using a quantitative proteomics-based approach com-
bined with a (partial) genome sequence.
After successful initial tests in S. coelicolor and
B. amyloliquefaciens demonstrating that protein expression pro-
files directly correlated to secondary metabolite levels, we went
on to identify the gene clusters responsible for production of
antimicrobial compounds observed in two soil isolates. Analysis
of the actinomycin producer Streptomyces sp. Che1 allowed
further refinement of filtering of the proteomics data, and the
technology was then applied to connect a biosynthetic gene
cluster to a juglomycin derivative produced by Streptomyces
sp. MBT70. Thus, natural product proteomining allows the iden-
tification of gene clusters for different classes of natural prod-
ucts; specifically, we applied the method to positively identify
the gene clusters specifying nonribosomal peptides and polyke-
tides in Streptomyces and a lantibiotic in Bacillus.
We employed quantitative proteomics based on labeling with
stable isotopes, which is a well-established technique that is
Chemistry & Biology
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metabolic incorporation of isotopes, but chemical modification
of peptides provided good results. Depending on instrument
availability, isobaric tags like iTRAQ or tandem mass tags might
be used instead for peptide modifications, because they allow
for the simultaneous comparisons of up to eight samples in
one proteomics run. The current method of dimethyl labeling is
limited to three comparisons per run, necessitating the use of
two runs to obtain the four comparisons that were used for
data filtering. However, dimethyl labeling is more cost-effective
(Kovanich et al., 2012) and, perhaps more importantly, yields
more data points as compared with MS/MS-based quantifica-
tion of isobaric labels.
Compared with other approaches for the identification of
expressed biosynthetic clusters, based on either proteomics
(Bumpus et al., 2009; Meier et al., 2009), transcriptomics (Qu
et al., 2011), or peptide/glycan fingerprinting (Kersten et al.,
2011; Kersten et al., 2013), the usage of expression levels should
allow the detection of all types of clusters specifying natural
products simultaneously. Moreover, because no specific se-
quences were targeted, expression levels of a majority of pro-
teins specified by the clusters could be determined and, for
the biosynthetic proteins in particular, were coregulated. For
instance, the central 18 CDSs of the actinomycin biosynthetic
gene cluster, containing the genes for the chain assembly pro-
teins and subunit tailoring (Keller et al., 2010), demonstrated
excellent agreement with the expected expression pattern.
This allows accurate determination of cluster members, as
described before for transcriptomic analysis of Aspergillus
nidulans (Andersen et al., 2013), and piecing together gene clus-
ters spread over multiple contigs.
To identify previously unreported biosynthetic clusters, full
genome sequencing is crucial (Albright et al., 2014). Fortunately,
in case of bacterial genomes, this is now a routine analysis and
continues to become more efficient and cost-effective. As an
alternative, RNA-Seq could be applied to determine expression
level changes in the transcriptome without prior sequence in-
formation. However, in this case two technological limitations
need to be overcome. First, quantification of repetitive gene
sequences, as often observed in NRPS and PKS, is inherently
difficult in RNA-Seq analysis as similar short reads might be
misinterpreted as multiple copies of the same transcript (Martin
and Wang, 2011). Second, clustering of proteomics hits on the
genome was found to be a particularly important criterion for
filtering of the results, and similar information on gene clustering
in RNA-Seq analysis is only obtained in case the genes are tran-
scribed as a polycistronic mRNA.
An unambiguous identifier for the bioactivity of interest, such
as an MS and/or NMR signal, significantly enhances the effec-
tiveness of natural product proteomining. The analysis becomes
more complicated when a bioactivity marker can represent
multiple bioactivities produced by the same species, such as
growth inhibition of an indicator strain as exemplified by a
second antimicrobial activity in Streptomyces sp. MBT70
produced under condition D (yeast extract). Subsequent NMR
analysis confirmed the production of an alternative bioactive
compound under this condition, the identity of which is currently
under investigation. Moreover, sufficient fluctuation of produc-
tion is essential for proper correlation of expression levels toChemistry & Biology 21,metabolite levels. The lower utility of the comparison between
fractions with low bioactivity (i.e., conditions D and E for Strepto-
myces sp. Che1) is a consequence of themarginal fluctuations in
protein expression levels, and such comparisons are therefore
less feasible. We recently analyzed the inducibility of antibiotic
production in a collection of over 800 actinomycetes from
mountain soils, under 40 different culturing conditions. The
eliciting conditions effected strong fluctuation in antibiotic
production, andmany of the actinomycetes produced antibiotics
against multidrug-resistant pathogens only under a few or even
just one of the 40 conditions (H.Z., et al., submitted). Because
‘‘silent’’ antibiotic gene clusters are by definition not expressed
significantly under routine growth conditions, their induction
under specific conditions will lead to a major increase in bio-
activity and protein expression levels, which is ideal for our
approach. Indeed, the technology was designed with exploiting
this property of previously unidentified natural products in mind.
In summary, we have developed an ‘omics-based approach
that exploits the direct correlation between bioactivity and pro-
tein expression profiles, offering an efficient and straightforward
way to identify the gene cluster responsible for the production of
a natural product of interest. Importantly, considering that this
method requires neither prior knowledge of gene sequences
nor structural information on the bioactive compound, it is uni-
formly applicable to all types of natural product clusters and,
theoretically, even to completely new types of clusters. This
will support quests for novel bioactive compounds, such as
the antimicrobials that are so badly needed to combat infectious
diseases associated with drug-resistant pathogens that
currently threaten the health of patients in the clinic.
SIGNIFICANCE
In the genomics era, where the number of genomes
sequenced increases rapidly, numerous gene clusters for
natural product biosynthesis are uncovered. Still, the exact
structure and production levels of a natural product can
often not be deduced from the DNA sequence alone. Natural
product proteomining is a method that allows linkage of a
bioactive compound to a gene cluster when a (partial)
genome sequence is available. This is achieved by compar-
ison of protein expression levels tometabolite levels under a
variety of growth conditions that effect differential produc-
tion of the natural product of interest. Quantitative prote-
omics is a well-established technique and can be executed
on a routine basis. Moreover, no prior knowledge is required
regarding the nature of the product or its gene cluster,
assuming that it is synthesized by proteins whose expres-
sion levels correlate with the levels of metabolite, which,
as we demonstrated, is typically the case. For this reason,
natural product proteomining is an expression-based tech-
nology that is equally applicable to all known classes of
compounds and might even be applied to new compound
classes. We validated the technology by identifying the
biosynthetic gene clusters for antibiotics in two soil isolates
of the Gram-positive bacterium Streptomyces. One cluster
specifies the biosynthetic proteins for actinomycin, whereas
the other specifies the biosynthetic proteins for juglomycin
C amide. In addition, the applicability to the discovery of707–718, June 19, 2014 ª2014 Elsevier Ltd All rights reserved 715
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Natural Product Proteomininglantibiotic production was demonstrated in the firmicute
Bacillus. In principle, by scaling up the number of conditions,
it should be possible to map all natural products from a
single organism to their respective biosynthetic gene clus-
ters. With that, we expect that the technology will facilitate
the identification of gene clusters for compounds of high
relevance, such as antibiotics for treatment of the rapidly
emerging multidrug-resistant pathogens.EXPERIMENTAL PROCEDURES
Strains and Growth Conditions
S. coelicolor A3(2) M145 was obtained from the John Innes Centre strain
collection. The dasR-null mutant (SAF29) (Rigali et al., 2006) and rok7B7-null
mutant (GAM33) (Swia˛tek et al., 2013) of S. coelicolor were described previ-
ously. B. amyloliquefaciens HIL-Y85/54728 was obtained from Novacta
Biosystems (Welwyn, Garden City, UK). Streptomyces strains Che1 and
MBT70 were obtained de novo from soil samples as described (H.Z., et al.,
submitted). All Streptomyces strains were grown as indicated according to
routine methods (Kieser et al., 2000).
S. coelicolorM145 and its congenic dasR and rok7B7 deletionmutants were
grown in adapted NMMP medium for 14N/15N labeling (Swia˛tek et al., 2013).
Samples were taken at late logarithmic phase when production of pigmented
antibiotics became apparent. 14N/15N-labeling experiments were performed in
duplicate with a label swap to avoid that differences in media composition
should affect the outcome of the proteomics experiments.
A seed culture of B. amyloliquefaciens was grown in TSB for 24 hr as
described (Appleyard et al., 2009), before transfer (1:50, v/v) to mersacidin
production medium, LB, or fresh TSB. Cultures were grown for 5 days at
30C. Proteomics samples were taken after 24 hr because protein levels
were too low after 5 days of growth.
Streptomyces strains Che1 andMBT70 were grown in liquid NMMPmedium
as described (H.Z., et al., submitted). Essentially, strains were grown in NMMP
containing 1% (w/v) glycerol and 0.5% (w/v) mannitol as carbon sources for
4–6 days, using five different additives to create varying growth conditions:
() (no additive), A (NaOH to pH 9), B (25 mM N-acetylglucosamine), C
(0.8% [w/v] Bacto peptone [Difco]), D (0.5% [w/v] Bacto yeast extract [Difco]),
and E (1 [MBT70] or 2% [Che1] [w/v] NaCl). For antibiotic activity assays,
M. luteus was spread onto LB agar plates, and 20 ml of spent medium were
placed on the plates. After growth at 30C overnight, the growth inhibition
zone was measured. No inhibition was observed when unused medium was
spotted.
Metabolite Analysis
For S. coelicolor, mycelium was extracted with methanol; the extract and
spent medium were analyzed directly by LC-MS for undecylprodigiosins and
desferrioxamines, as detailed in Supplemental Experimental Procedures.
Spent medium samples of Streptomyces sp. Che1 and B. amyloliquefaciens
were mixed 1:1 (v/v) or 1:10 (v/v) with matrix solution, respectively, and
analyzed by MALDI-ToF MS in the positive ion reflectron mode as detailed
in Supplemental Experimental Procedures. For Streptomyces sp. MBT70,
20 ml of spent medium of five biological replicates was liquid-liquid partitioned
using 20 ml EtOAc. This was repeated twice, after which the combined EtOAc
fractions were concentrated by rotary evaporation at 40C and subjected to
NMR analysis. NMR conditions have been described previously (Kim et al.,
2010) and are detailed in Supplemental Experimental Procedures.
For multivariate data analysis, 1H NMR spectra were automatically reduced
to ASCII files using AMIX (v. 3.7, Bruker Biospin). Spectral intensities were
scaled to TMSP and reduced to integrated regions of equal width (0.04
ppm) corresponding to the region of d0.3–d10.00. The region of d4.7–d5.0
and d3.28–d3.34 were excluded from the analysis because of the residual
signal of H2O and CH3OH-d4, respectively. PLS-DA was performed with the
SIMCA-P software (v. 13.0, Umetrics, Umea˚, Sweden) with unit variance
scaling methods.
For naphthoquinone purification, extracts of the five biological replicates of
condition E were pooled and fractionated by reversed phase HPLC, based on716 Chemistry & Biology 21, 707–718, June 19, 2014 ª2014 Elsevierabsorption at 410 nm, as detailed in Supplemental Experimental Procedures.
Fractions were tested for antibiotic activity as described above. Active frac-
tions were subjected to NMR analysis and, after reconstitution in 1:1 (v/v)
H2O/acetonitrile with 0.1% (v/v) formic acid, analyzed on a Thermo LTQ-orbi-
trap mass spectrometer equipped with an ESI source.
Illumina Sequencing
Illumina/Solexa sequencing on Genome Analyzer IIx was outsourced
(ServiceXS, Leiden, The Netherlands). One hundred nucleotide paired-end
reads were obtained and analyzed as detailed in Supplemental Experimental
Procedures.
Quantitative Proteomics Analysis
Mycelia or Bacillus cells were harvested by centrifugation, washed, and soni-
cated for 5 min at 12 W output power using 5 s on/5 s off intervals in 100 mM
Tris/HCl (pH 7.5), 10 mM MgCl2, 5 mM dithiothreitol. Debris was removed by
centrifugation at 16,000 3 g for 10 min at 4C. Protein concentration of the
extracts was determined using a Bradford protein assay, using BSA as
standard. 14N-labeled and 15N-labeled mycelial extracts were mixed 1:1 for
protein content, and proteins were separated by SDS-PAGE on mini-Protean
TGX Any kD gels (Bio-Rad) using a broad range protein ladder (Bio-Rad),
followed by in gel digestion, all as described (Swia˛tek et al., 2013). In-solution
digestion and dimethyl labeling of Che1, MBT70, and Bacillus extracts were
performed as described (Gubbens et al., 2012), using 0.167 mg of total protein
per sample. Labeled peptides were mixed 1:1:1 to yield mixtures containing
0.5 mg of protein each. Acetonitrile was removed using a vacuum concen-
trator, and peptides were subjected to SCX fractionation as detailed in Supple-
mental Experimental Procedures. LC-MS/MS analysis on an LTQ-Orbitrap
(Thermo, Waltham, MA) for both gel-extracted peptides (14N/15N labeling)
(Florea et al., 2010) and SCX fractions (dimethyl labeling) (Gubbens et al.,
2012) was performed as described, respectively.
Data analysis of 14N/15N labeled samples using MSQuant (Mortensen et al.,
2010) has been described elsewhere (Swia˛tek et al., 2013). Data analysis of
dimethyl-labeled samples was performed using MaxQuant 1.2.2.5 (Cox and
Mann, 2008) as described (Gubbens et al., 2012). For B. amyloliquefaciens
HIL-Y85/54728, the B. amyloliquefaciens FZB42 complete proteome set
(Uniprot 2012_10) with 98.5% sequence identity (Herzner et al., 2011) was
appended with the ten mersacidin-producing proteins annotated for
B. amyloliquefaciens HIL-Y85/54728 (Uniprot). For the Streptomyces strains
Che1 and MBT70, identified CDSs were translated to obtain a protein
database, and the two mixtures obtained for each strain were analyzed in
one MaxQuant run. Normalized protein expression ratios were split in three
equally sized quantiles (up, unchanged, or down). Expression ratio filtering
was based on selection of the expected quantile for each comparison.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, three tables, and three data sets and can be found with this
article online at http://dx.doi.org/10.1016/j.chembiol.2014.03.011.
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